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are not well understood, xanthan gum has previously been used to bind drugs and alter their 48 pharmacokinetics. Thus, xanthan gum may alter the activity of the oral antibiotics used to make 49 the microbiota susceptible. Future research should further characterize how this and other 50 common dietary fibers interact with drugs. 51 52 IMPORTANCE (150 words) 53
INTRODUCTION 63
The microbiota plays an integral role in gut health by aiding in digestion and regulating 64 colonic physiology (1, 2) . Manipulating the microbiota to improve human health by either 65 administering live bacteria (i.e. probiotics) or adding nondigestible, microbiota-accessible 66 ingredients to the host's diet (i.e. prebiotics) has become a prominent area of biomedical 67 research. While probiotics rely on exogenously added microbes for their effect, diet modification 68 uses indigenous microbes already present in the gut to generate the beneficial effects described 69 above. While the community as a whole may remain intact, diet modification can affect subsets 70 of the community that are better suited to utilize the altered nutrient composition (3). This effect 71 is most prominent in hunter-forager societies where seasonal dietary changes modulate the 72 microbiota (4). In Western diets, a great emphasis has been placed on the types and 73 abundance of host indigestible fiber polysaccharides that are only accessible by the microbiota, 74 such as resistant starch, inulin or the fibers naturally present in fruits, vegetables and whole 75
grains. 76
Dietary fiber promotes microbial short-chain fatty acid (SCFA) production. While SCFA 77 profiles are unique from individual to individual, they provide a variety of benefits including 78 increased colonic barrier integrity and decreased inflammation (5-10). Depending on the 79 structure of the fiber backbone and side chains, polysaccharides select for unique taxa and as a 80 result, unique fermentation profiles (11) . Several key species may be responsible for degrading 81 the fiber's carbohydrate structure, the byproducts of which go on to be metabolized by a number 82 of additional taxa (12). Butyrate, a short chain fatty acid and product of fiber degradation, has 83 been linked to increased gut barrier integrity and decreased inflammation (13) (14) (15) . Fiber 84 degradation and SCFA production are also associated with clearance of Clostridioides difficile, 85 formerly known as Clostridium difficile, following fecal microbiota transfer (FMT) (16). Switching 86 mice to a high fiber diet while colonized with C. difficile increased SCFA concentrations and also 87 cleared the infection (17). Since C. difficile infection represents a significant healthcare burden, 88 characterizing how these polysaccharides shape the gut environment and impact C. difficile's 89 ability to colonize will provide insight into how they might be used to improve patient outcomes. 90 Some polysaccharides included in food are added to alter texture rather than for 91 nutritional benefit. Xanthan gum, synthesized by the bacteria Xanthamonas campestris, is a 92 common food additive used as a thickener, particularly in gluten free foods, where industrial 93 production is worth approximately $0.4 billion each year. Xanthan gum structure consists of 94 (1→4)-linked β-D-glucose with trisaccharide chains containing two mannose and one glucuronic 95 acid residues linked to every other glucose molecule in the backbone, with possible acetylation 96 on the first branching mannose and 3,6-pyruvylation on the terminal mannose (18). These 97 negatively charged side chains give xanthan gum its viscous, gel-like properties. Although not 98 specifically included in foods for their potential prebiotic activity, bacteria can degrade xanthan 99 gum to increase fecal SCFA concentrations (19, 20) . However, little is known about what 100 bacterial taxa are involved in these transformations. 101
This study investigated the effect of xanthan gum on the bacterial composition of specific 102 pathogen-free C57Bl/6 mice and its effect during an antibiotic model of C. difficile infection. Our 103 goal for this paper was to (i) characterize the effects of xanthan gum on the mouse microbiota 104 and (ii) characterize the effects of xanthan gum on C. difficile colonization. Surprisingly, we 105 found that xanthan gum administration alters mouse susceptibility to C. difficile colonization by 106 maintaining the microbiota during antibiotic treatment. 107
108

RESULTS
109
Xanthan gum maintains the abundance of microbial taxa during cefoperazone treatment 110
Using C57Bl/6 mice, we tested the effects of xanthan gum on the microbiota using 111 mouse models designed to study the effects of antibiotic perturbation. Since our initial goal was 112
to study the effects of xanthan gum on C. difficile infection in mice, these models entailed 113 multiple days of antibiotic treatment necessary to make the microbiota susceptible to C. difficile 114 ( Fig. 1A, Fig. S1A ). Some mice were kept on a standard mouse chow diet; the rest were put on 115 an equivalent diet supplemented with 5% xanthan gum. 116
In the cefoperazone mouse model, 16S rRNA-gene analysis of mouse fecal samples 117 revealed a baseline microbiota dominated by Bacteroidetes (~45%) and Firmicutes (~35%), with 118 the remainder of the community composed of Actinobacteria, Proteobacteria and 119 Verrucomicrobia ( Fig. 1B & C) . Following cefoperazone treatment of mice on standard chow, 120
Lactobacillaceae predominated a fluctuating community, as evidenced by increased mean Bray-121
Curtis distances between timepoints. While we also observed higher dissimilarity in the xanthan 122 gum chow group following antibiotics, microbial communities were significantly more similar in 123 the xanthan gum chow group compared to the standard chow group, as measured by Bray-124
Curtis distances. However, the relative abundance of bacterial taxa remained similar after 125 cefoperazone treatment in mice fed 5% xanthan gum (Fig. 1C ). These protective effects are 126 reflected in a significantly higher Shannon Diversity and absolute abundance of fecal bacteria in 127 xanthan gum-fed mice following cefoperazone treatment compared to those on standard chow 128 ( Fig. 1D & E) . These data suggest that high concentrations of xanthan gum prevent 129 cefoperazone-mediated alterations to the mouse microbiota. To see if xanthan gum had a 130 similar protective effect for other antibiotics, we also used an oral antibiotic cocktail model 131 coupled with intraperitoneal clindamycin, which has also been shown to render mice susceptible 132 to C. difficile colonization (21, 22) . However, the microbiota differences between chow groups 133 were less pronounced ( Fig. S1B & C) . Taken together, our results show that xanthan gum 134 administration maintains both diversity and overall abundance of microbes in the gut during 135 cefoperazone treatment. 136
Using the linear discriminant analysis algorithm LEfSe, we identified 35 OTUs that were 137 significantly increased two days following the switch from standard to xanthan gum chow (Fig. 138 S3) . We also observed a shift in bacterial metabolism marked by significantly higher butyrate 139 and propionate concentrations in mice on xanthan gum chow compared to those on standard chow ( Fig. S4 ). No significant OTUs were identified comparing the same timepoints in the 141 standard chow group. Following cefoperazone treatment, 4 OTUs were increased and 80 OTUs 142 were decreased in the xanthan gum group (Fig. S5 ). In the standard chow group, only 1 OTU 143 (Lactobacillus) significantly increased following cefoperazone treatment (Fig. S6) . 144
Unsurprisingly, 48 of the 112 OTUs that were negatively correlated with cefoperazone treatment 145 in the standard chow group were also negatively correlated in the xanthan gum group. 146 147
Xanthan gum-mediated microbiota protection limits C. difficile colonization 148
Two days after the mice were removed from cefoperazone, they were challenged with C. 149 difficile strain 630g spores administered by oral gavage. By monitoring feces for colony-forming 150 units (both vegetative cells and spores), we observed approximately 1x10 6 CFU/g feces C. 151 difficile in mice on standard chow 1 day post-gavage (Day 15), which rose to 1x10 7 for the 152 duration of the experiment (Fig. 2 ). However, when on xanthan gum, only a small number of 153 CFU was observed 1 day post-gavage but by day 4 (Day 19) all mice had cleared C. difficile 154 The use of dietary polysaccharides for their beneficial health effects, either directly on 160 the host or indirectly through the microbiota, has been widely demonstrated (15, 19) . In the 161 context of C. difficile, diet may play a role in pathogen evolution, such as with trehalose, or 162 influence colonization resistance, such as with dietary fiber and zinc (17, (23) (24) (25) . Dietary 163 alteration may shape the intestinal environment by altering the nutrients available or by 164 modulating the concentrations of compounds toxic to C. difficile, such as secondary bile salts. 165
As a common food additive, xanthan gum's physicochemical properties are well known (18). 166
However, its impacts on the gut microbiota are poorly understood. Although we were not able to 167 test whether xanthan gum enriches for fiber-degrading bacteria to increase colonization 168 resistance, we did observe that xanthan gum interferes with the activity of orally administered 169 antibiotics to protect mice from C. difficile colonization. These protective effects vary by type of 170 antibiotic. While xanthan gum may have enriched for taxa capable of degrading it, these 171 changes were minor compared to the much larger differences observed between diet groups 172 during antibiotic treatment. 173
As a third-generation cephalosporin, cefoperazone has broad-spectrum efficacy (26, 27) . 174
As a result, it is not surprising that, in the standard chow group, it had a significant impact on 175 microbiota community structure. These results agree with previously published work on the 176 effect of cefoperazone on the murine gut microbiota (28, 29) . As demonstrated in this study, diet 177
can affect antibiotic efficacy in unexpected ways. While both bacterial diversity and abundance 178 were maintained in mice on xanthan gum, the similarities in OTUs identified by LEfSe between 179 the two groups indicates that cefoperazone affected the microbiota in both groups but was 180 attenuated in the xanthan gum chow group. Since we observed similar antimicrobial activity 181 against an Escherichia coli strain ECOR2 lawn from fecal extracts obtained during antibiotic 182 administration between diet groups and no inhibitory activity in fecal extracts from non-antibiotic 183 treated control mice (data not shown), our data suggests that while still active, cefoperazone's 184 efficacy was interrupted in vivo. 185
By at least partially protecting the microbiota from the effects of cefoperazone, xanthan 186 gum administration preserved colonization resistance to C. difficile. Colonization resistance 187 comprises a variety of mechanisms including the metabolism of bile salts and competition for 188 nutrients (30). Microbially-modified secondary bile salts inhibit C. difficile outgrowth much more 189 than their primary precursors (31). Microbial metabolism mediates a variety of modifications to 190 primary bile salts, including deconjugation by Lactobacillus and Bifidobacterium sp. as well as 191 7α-dehydroxylation by Clostridium sp. (32) (33) (34) (35) . The lack of secondary metabolites produced by 192 these taxa has been correlated with a lack of colonization resistance (31, (36) (37) (38) . The 193 indigenous microbiota also prevents C. difficile from establishing itself within the colonic 194 environment by limiting the nutrients available for growth (39, 40) . A number of taxa, including 195 the Lachnospiraceae, have been shown to provide resistance to C. difficile colonization, which 196 may occur through niche competition (41, 42) . Despite increased SCFA concentrations 197 immediately following xanthan gum administration, direct alterations of the microbiota by 198 xanthan gum did not appear to affect colonization resistance on the day of C. difficile gavage 199 since SCFA concentrations had returned to baseline levels. By protecting the microbiota during 200 antibiotic treatment, xanthan gum likely maintained these metabolic mechanisms to exclude C. 201 difficile from the gut. This suggested that while the community was altered, enough bacterial 202 taxa remained to exclude C. difficile. 203
While we did not demonstrate a mechanism for xanthan gum's effect, its gel-like nature 204 may interrupt the activity of antibiotics by altering their pharmacokinetics. Several large 205 polysaccharides with negatively charged or polar sidechains, such as hydroxypropylmethyl 206 cellulose, mannan oligosaccharides and guar gum, increase the excretion of cholesterol and 207 bile salts in feces by limiting their absorption (43-49). While not previously reported, xanthan 208 gum may also interact with these compounds. Similarities between the chemical structures of 209 these sterol ring-containing compounds and of cefoperazone may result in interactions between 210 xanthan gum and the antibiotic. The greater efficacy of the antibiotic cocktail plus clindamycin 211 model against the microbiota is likely due to varied interactions with the five antibiotics in 212 addition to the effect of the intraperitoneal injection of clindamycin. While potential alterations to 213 the bile salt pool by xanthan gum may have limited C. difficile germination, we observed more 214 fecal CFUs 1 day post-gavage (day 15) than what we used to inoculate the mice on day 14, 215
suggesting that any disruptions to enterohepatic circulation did not prevent germination as there 216 was some vegetative cell outgrowth. Furthermore, we have previously observed that few spores 217 (i.e. <100) are sufficient to infect mice, suggesting that it was not a small inoculum that 218 protected the mice (unpublished data). 219
Polysaccharide-drug interactions are frequently explored as means to delay drug release 220 in vivo. When mice consume xanthan gum in their chow, orally administered antibiotics may 221 become trapped inside the gel formed by hydrated xanthan gum. Previous research has shown 222 that xanthan gum would provide time-dependent release that occurs at a slower rate than other 223 large, polar polysaccharides. For example, hydroxypropylmethyl cellulose requires three times 224 the concentration to achieve similar drug binding levels as xanthan gum (50, 51). The binding 225 affinity of xanthan gum is pH-dependent, where higher pH limits drug release due to increased 226 integrity of the polymer structure (51). Furthermore, environments with higher ionic strength as 227 well as the presence of other polysaccharides increases xanthan gum's drug retaining efficiency 228 (52, 53). Thus, the colonic environment would be conducive for high xanthan gum affinity for 229 binding compounds such as cefoperazone due to its relatively higher pH. 230
In our study, dietary xanthan gum administration protected the microbiota during 231 antibiotic treatment leading to the exclusion of C. difficile from the gut. While our study suggests 232 that a common dietary polysaccharide interacts with the effects of antibiotics, there are several 233 limitations that merit future research. Since few individuals will consume xanthan gum at the 234 concentrations we used, titering in lower doses of xanthan gum to get closer to physiological 235 levels would elucidate the effects of xanthan gum in a normal human diet. Future research 236 should also characterize how polar polysaccharides such as xanthan gum interact with 237 compounds in the gut. This would be important for understanding drug pharmacokinetics as well 238 as the impact of xanthan gum on bile salts and enterohepatic circulation. Further work 239 characterizing this common food additive would provide a greater understanding not only of how 240 it is degraded in the gut it but also the potential positive effects of its fermentative byproducts. Animals and housing. We obtained five-to eight-week old, male and female mice from 248 an established breeding colony at the University of Michigan. These mice were originally 249 sourced from Jackson Labs. We housed mice in specific pathogen-free and biohazard AALAC-250 accredited facilities maintained with 12 h light/dark cycles at an ambient temperature of 22 ±2 o C. 251
All bedding and water were autoclaved. Mice received gamma-irradiated food (LabSupply 5L0D 252
PicoLab Rodent Diet, a gamma-irradiated version of LabSupply 5001 Rodent LabDiet) or an 253 equivalent diet with 5% xanthan gum added (95% LabSupply 5001 Rodent LabDiet, 5% xanthan 254 gum [Sigma]; gamma-irradiated by manufacturer). We housed mice in groups of two to five 255 animals per cage, with multiple cages per treatment group. 256
All cage changes, infection procedures, and sample collections were conducted in a 257 biological safety cabinet (BSC) using appropriate sterile personal protective equipment between 258 cage contacts. The BSC was sterilized with Perisept (Triple S, Billerica, MA) between treatment 259 groups. Gloves were thoroughly sprayed with Perisept between each cage and completely 260 changed between groups. A description of the metadata for the mouse experiments including 261 cage number and treatment group can be found in Table S1 . 262
Xanthan gum-cefoperazone mouse model. To investigate the effect of xanthan gum 263 on cefoperazone treated mice, we switched mice to a diet containing 5% xanthan gum on day 264 zero. Two days later, we gave mice 0.5 mg/mL cefoperazone in the drinking water for 10 days 265 as previously described to render the mice susceptible to C. difficile colonization (54, 55). We 266 changed the antibiotic-water preparation every 2 days. Following 10 days of cefoperazone, we 267 switched mice to Gibco distilled water. We orally gavaged mice with between 10 2 and 10 4 C. 268 difficile 630g spores or vehicle control (sterile water) 2 days after removing the mice from 269 antibiotics. Spores were prepared as previously described and then suspended in 200 uL of 270
Gibco distilled water and heat-shocked (55). Viable spores were quantified immediately after 271 gavage using taurocholate cycloserine cefoxitin fructose agar (TCCFA) as previously described 272 (55). 273
Xanthan gum-antibiotic cocktail mouse model. To investigate the effect of xanthan 274 gum on an alternative antibiotic model (antibiotic cocktail with clindamycin), we switched mice to 275 a 5% xanthan gum diet on day zero and then put on an antibiotic cocktail (0.4 mg/mL 276 kanamycin, 0.035 mg/mL gentamicin, 850 U/mL colistin, 0.215 mg/mL metronidazole, and 0.045 277 mg/mL vancomycin) for 3 days in their drinking water as previously described (21, 22) . On day 278 5, we removed mice from oral antibiotic administration and returned them to regular drinking 279 water. On day 7, mice were given an intraperitoneal (IP) injection of clindamycin hydrochloride 280 (10 mg/kg). 1 day following the ip injection, we orally gavaged mice with between 10 2 and 10 4 C. 281 difficile 630g spores as described above. 282
Quantitative culture. We suspended fresh fecal pellets in sterile, pre-reduced Gibco 283 PBS (ThermoFisher) using a ratio of 1 part feces to 9 parts Gibco PBS, wt/vol (ThermoFisher, 284 Waltham, MA). We serially diluted these suspensions, plated them on TCCFA, and incubated 285 the plates anaerobically at 37 o C for 18-24 hrs before counting colonies. 286 16S rRNA-gene qPCR. We suspended fecal pellets in PBS as described above and 287 centrifuged them at 6,000 rpm for 1 minute. 100-400 uL of supernatant was removed for 288 metabolite analysis. Using the sedimented fecal content, we performed DNA extractions using 289 the DNeasy PowerSoil Kit (Qiagen, Germantown, MD), according to the manufacturer's 290 protocol. We immediately stored extracted DNA at -20°C until further use. We then performed 291 qPCR on a LightCycler® 96 thermocylcer (Roche, Basel, Switzerland) using the PrimeTime® 292
Gene Expression Master Mix (IDT, Coralville, IA) and a set of broad range 16S rRNA gene 293 primers (56). All fecal DNA was amplified in triplicate with Escherichia coli genomic DNA 294 standards in duplicate and negative controls in triplicate. The LightCycler reaction conditions 295 were as follows: 95°C for 3 minutes, followed by 45 cycles of 2-step amplification at 60°C for 60 296 s and 95°C for 15 s. C q values for each reaction were determined using the LightCycler® 96 297 software, and fecal DNA concentrations were determined by comparing C q values to the 298 standards in each plate and normalizing to each individual sample's fecal mass. We used 299
Welch's 2-Sample T-Test to test for significance. 300 Short-chain fatty acid analysis. 100 uL of fecal supernatants were filtered at 4 o C using 301 0.22 micron 96-well filter plates and stored at -80 o C until analysis. We transferred the filtrate to 302 1.5 mL screw cap vials with 100 uL inserts for high performance liquid chromatography analysis 303 (HPLC) and then randomized them. We quantified acetate, propionate, and butyrate 304 concentrations using a refractive index detector as part of a Shimadzu HPLC system (Shimadzu 305 Scientific Instruments, Columbia, MD) as previously described (8). Briefly, we used a 0.01 N 306 H 2 SO 4 mobile phase through an Aminex HPX87H column (Bio-Rad Laboratories, Hercules, 307 CA). Sample areas under the curve were compared to volatile fatty acid standards with 308 concentrations of 40, 20, 10, 5, 2.5, 1, 0.5, 0.25, and 0.1 mM. Through blinded curation, we 309 assessed baseline and peak quality and excluded poor quality data if necessary. 310 DNA Extraction and Illumina MiSeq sequencing. The detailed protocol for DNA 311 extraction and Illumina MiSeq sequencing was followed as described in previous publications 312 with modifications (55). Briefly, 200-300 uL of 10x diluted fecal pellet was submitted for DNA 313 isolation using the MagAttract PowerMicrobiome DNA isolation kit (Qiagen, Germantown, MD). 314
Samples were randomized into each extraction plate. To amplify the DNA, we used barcoded 315 dual-index primers specific to the V4 region of the 16S rRNA-gene (57). Negative and positive 316 controls were run in each sequencing plate. Libraries were prepared and sequenced using the 317 500-cycle MiSeq V2 reagent kit (Illumina, San Diego, CA). Raw FASTQ files, including the 318 appropriate controls, were deposited in the Sequence Read Archive (SRA) database (Accession 319 #'s: XXXXXXXXXX; Note: the authors have submitted the sequences, but they are still being 320 processed by the SRA).
Data processing and microbiota analysis. 16S rRNA-gene sequencing was 322 performed as previously described using the V4 variable region and analyzed using mothur. 323
Detailed methods, processed read data, and data analysis code are described on GitHub 324 (https://github.com/mschnizlein/xg_microbiota). Briefly, after assembly and quality control, such 325 as filtering and trimming, we aligned contigs to the Silva v.128 16S rRNA database. We 326 removed chimeras using UCHIME and excluded samples with less than 5000 sequences. We 327 binned contigs by 97% percent similarity (OTU) using Opticlust and then used the Silva rRNA 328 sequence database to classify those sequences. Alpha and beta diversity metrics were 329 calculated from unfiltered OTU samples. We used LEfSe to identify OTUs that significantly 330 associated with changes across diets and antibiotic treatments (58). We performed all statistical 331 analyses in R (v.3.5.2) . Table S1 : Mouse experiment and analysis metadata 411 Table S2 : Mouse sequencing metadata from the cefoperazone model 412 Table S3 : Mouse sequencing metadata from the antibiotic cocktail with clindamycin 413 model 414 Xanthan Gum 
